CD79A and autoimmune polyendocrinopathy: Although aβ2GPI IgA is not currently included as diagnostic criteria for APS according to 2023 ACR/EULAR antiphospholipid syndrome classification criteria (1), emerging evidence indicates that aβ2GPI IgA can form high-affinity complexes with the β2GPI protein (5, 6).